Print ISSN 0976-0245 · Online ISSN 0976-5506 Submit an article

Indian Journal ofPublic Health Research & Development

An International Journal · Quarterly · Open access · Double-blind peer reviewed

Home / Article Submission

Article Submission

How to prepare and submit a manuscript, what is required, and what to expect after you submit.

How to submit

We encourage you to submit your manuscript through the OJS platform, as it keeps the publication process transparent and visible. All first-time users need to register themselves. Registration is free. Once registered, authors can use their username and password to submit and track their articles.

  • If you are unable to submit on OJS, or have any problems, email your manuscript or query to editor.ijphrd@gmail.com.

Required documents

  • A signed cover letter, in the format the journal provides. It must name the ethics committee, with its approval date and number.
  • An anonymised manuscript for double-blind review.
  • A signed copyright licensing form.

Both forms are mandatory. Manuscripts without the cover letter or the copyright form are not considered for review.

Relevant policies

All authors are advised to read the following policies first, before submitting an article to the journal, and to agree to them.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication.
  • Authors continue to retain publishing rights to the article without restrictions.
  • Articles in the Indian Journal of Public Health Research & Development are open access articles, which permit use, distribution and reproduction in any medium, provided the original work and source are properly cited.

Definition of authorship as per our journal

We refer to the ICMJE guidelines to define authorship and contributorship. All authors are required to have made significant contributions to the intellectual content of the paper and meet at least one condition in each of the four categories of contributions:

  1. Category 1: Conception and design, acquisition of data, analysis and interpretation of data.
  2. Category 2: Drafting of the manuscript, critical revision of the manuscript for important intellectual content.
  3. Category 3: Final approval of the version to be published.
  4. Category 4: Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Authors must ensure that all individuals who have made substantial contributions to the work reported in the manuscript (e.g., data collection, writing, or editing assistance) but do not meet the authorship criteria are named in an acknowledgement section within the manuscript. Authors must also confirm that all individuals named in the acknowledgement section have provided written permission to be named.

By submitting your manuscript to this journal, you affirm that both you and the other authors linked to the manuscript adhere to the criteria for authorship.

Conflicts of interest statement

A conflict of interest arises in a manuscript when the author is associated with activities that might unduly influence their judgment, regardless of whether this influence occurs. Financial connections with industry, such as employment, consultancies, stock ownership, honoraria, grants, or expert testimony, either personally or through immediate family, are typically regarded as significant competing interests. Should such conflicts exist, authors are required to disclose them during manuscript submission.

Statement on the incorporation of artificial intelligence (AI) in scientific writing

The utilisation of Artificial Intelligence (AI) technologies, specifically Large Language Models (LLMs) like ChatGPT, is allowed solely for the enhancement of language and not for deriving insights and/or commentary. This usage must be thoroughly documented in the methods section. It is imperative that AI is not credited or listed as an author.

Ethical policies

All studies involving human and animal subjects must address ethical considerations.

  • When reporting research on human subjects, authors must specify whether the procedures align with the ethical standards of the responsible committee on human experimentation (institutional or regional) and comply with the Declaration of Helsinki of 1964, as revised in 2024.
  • All studies are strongly advised to obtain approval from an Institutional Ethics Committee (IEC) or Institutional Review Board (IRB). However, ethical clearance is mandatory for any research involving interventions on human subjects or animals, especially studies that include minors, disadvantaged populations, or sensitive interventions.
  • The cover letter should explicitly state the name of the ethics committee clearing the study, along with the date and number of the approval.
  • IJPHRD reserves the right to request a copy of the relevant document as needed.
  • Even if a study has been approved by a Research Ethics Committee, editors may express concerns about the ethical aspects of the work during the review process.
  • Authors may be asked to provide more detailed information and justify the ethical and moral aspects of the research.
  • Editors may request contact details of the research ethics committee for further enquiry.
  • IJPHRD editors may consult with editorial colleagues, the Committee on Publication Ethics (COPE, WAME or ICMJE), or ethical advisors to assess the ethical aspects of an article, and retain the right to reject a manuscript on ethical grounds, irrespective of institutional ethics committee approval.
  • In addition to manuscript rejection, the journal reserves the right to communicate ethical concerns to the head of the author's institution or the medical council, to prevent unethical practices and safeguard patients.

Animal research and reporting policy

All studies involving animals must comply with recognised ethical and regulatory standards governing animal care and use. Authors should ensure adherence to applicable national guidelines, such as the NACLAR Guidelines (Singapore), NIH Guide for the Care and Use of Laboratory Animals (U.S.), or equivalent frameworks. Ethical approval must be obtained from an Institutional Animal Care and Use Committee (IACUC) or equivalent ethics body before the research begins, and details of this approval should be stated in the manuscript.

Reporting of animal experiments must follow the ARRIVE (Animal Research: Reporting of In Vivo Experiments) Guidelines to ensure transparency and reproducibility. The Editorial Board reserves the right to request evidence of ethical approval and ARRIVE compliance at any stage of submission, review, or publication. Failure to provide this documentation may lead to rejection of the manuscript.

In the case of identifiable photographs and/or medical data of research subjects, particularly minors and the deceased, informed consent should be obtained from the subject themselves, legal guardians or next of kin, respectively. The consent form is available below. The identity of the patient in clinical photographs should be masked by suitable methods, and any sensitive medical data should be anonymised.

Funding sources

Authors must disclose all financial and material support received for the research, providing details such as grant number and funding agency.

Type of article and manuscript format

A submitted manuscript can be original research, a case report or a review article. For guidelines on the types of articles, see the document below.

A Word template with the recommended manuscript format is available below.

Enhancing public health impact: key considerations for IJPHRD submissions

Given the extensive reach of IJPHRD, authors are advised to address the following questions to ensure their research resonates with a diverse audience, including community medicine professionals, social workers, and policymakers. Clear takeaways from the research will improve its relevance and citability. Authors are requested to address and summarise each of these in the Discussion/Conclusion section.

  1. Research question/hypothesis: What is the central research question or hypothesis of your study, and how does your research address it?
  2. Existing work and methodology: What existing work has been done on this topic, and how has it informed your hypothesis and research methodology?
  3. Novel contributions: What are the new aspects of your research? How does your study add to the current discourse on this topic?
  4. Relevance to public health: How is your research relevant to the public health community, specifically community medicine professionals, social workers, and policymakers?
  5. Future research directions: What could be potential future research topics and areas stemming from your study?

By addressing these key points, authors can significantly enhance the impact and clarity of their research, making it more valuable to the public health community and beyond.

Publication process and criteria for acceptance

A manuscript will be reviewed for possible publication with the understanding that it is being submitted exclusively to IJPHRD and has not been published, simultaneously submitted, or accepted for publication elsewhere. The journal requires that authors authorise one among them (the corresponding author) to communicate with the journal regarding all matters related to the manuscript. All received manuscripts are duly acknowledged.

Upon submission, editors initially review all manuscripts for suitability for formal review. Manuscripts may be rejected at this stage if they lack originality, have serious scientific or technical flaws, fail to convey a significant message, lack public health relevance, or do not conform to the journal's guidelines. The initial screening decision will typically be communicated within one week of submission completion.

Including the epidemiology of clinical conditions and/or the prevalence of psycho-social conditions is mandatory.

We are dedicated to upholding high editorial standards and maintaining the integrity of our journal. Our commitment to quality is reflected in our rigorous peer review process, which typically takes 4–5 weeks. Here is an overview of the evaluation process your manuscript will undergo after submission:

  1. Submitting the manuscript

    We encourage you to submit the manuscript through the OJS platform, as it maintains transparency and visibility of the publication process. If you are unable to submit on OJS, you can email your manuscript to editor.ijphrd@gmail.com.

  2. Relevance to the aim and scope

    If your article aligns with the journal's scope, it will proceed. Otherwise, the editor may suggest incorporating a relevant lens or may reject your article.

    Rejection reasons:

    • Out-of-scope submissions.
    • Lack of novelty in the research subject.
    • Insufficient inclusion of necessary elements, such as research methods.
    • Evidence of research misconduct.
    • More than 10% plagiarism (we use paid Similarity Check/iThenticate services and will check each manuscript).
    • Inability to provide necessary ethical clearances and consent from research subjects.
  3. Peer review process

    Upon the editor's approval, a double-blind peer review will be initiated, involving subject matter experts. Following the review, your manuscript will be returned with comments.

  4. Author addresses comments

    Implement the necessary revisions based on the peer review comments and resubmit the revised manuscript to the editor.

  5. Intimation of acceptance

    If the editor is satisfied, you will be informed of your manuscript's acceptance, along with details about the publication timeline. Manuscript handling charges will be required, and an acceptance letter will be issued.

  6. Pre-release

    Before publication, you will receive a pre-release version of your article. Please review it thoroughly and communicate any essential changes to us.

Double-blind peer review guidelines

We require an anonymised manuscript for our double-blind peer review process, meaning that author information will be concealed from peer reviewers. When submitting your manuscript, please eliminate any identifying details, such as authors' names or affiliations. Additionally, ensure that the manuscript is appropriately prepared for double-blind review by following these guidelines:

  • Use the third person to refer to previously published work by the authors. For instance, write “Sharma and Iyer (2015) have demonstrated” rather than “we/the authors have previously demonstrated (Sharma & Iyer, 2015)”.
  • Ensure figures and tables do not include any references to author affiliations.
  • Omit acknowledgements and any mentions of funding sources.
  • Provide these details, including declarations of potential conflicts of interest, on the title page, which is not shared with reviewers. The format for the title page is available on the journal website.
  • Exercise caution in choosing file names, and anonymise the file’s “Properties”. If using Office 2007 or later, consider employing the Document Inspector tool before submission.
  • Be vigilant to avoid inadvertently including identifying information within the manuscript, as it will be shared with the reviewers.

Change in authorship or contributorship

Once an article has been submitted and the review process is underway, changes to authorship are discouraged. If a change to the authors or their order is needed before publication, we require explicit consent from all the authors. This consent should be provided either through official email addresses or by submitting a no-objection certificate on their institution's letterhead.

If there is a change in authorship or contributorship after publication, we will follow the same process of requiring explicit consent from all authors. We can make the authorship and contributorship changes on platforms controlled by us, primarily the journal website and OJS, but we cannot guarantee that the changes will be reflected on third-party platforms and databases that index the journal.

Article withdrawal process

You can withdraw your article at any time before publication. However, we may not be able to issue a full refund, especially if your article has been through the review process, since we have invested resources in the review. We will evaluate refunds on a case-by-case basis and may issue refunds to authors under financial duress. We recommend that you inform us about your intention to withdraw as soon as possible.

Publication charges policy

We operate open access publications, which means we do not charge for online subscriptions to our journal. Our primary goal is to establish high-quality multidisciplinary research platforms. The deliberate choice of an open-access model is driven by the intention to eliminate cost barriers for researchers, especially those based in developing countries, enabling unrestricted access to top-tier research.

To sustain the quality of our journal, nominal publication fees are charged to authors. These fees contribute to covering essential costs associated with maintaining a high-standard publication. Key expense areas include:

  • Host and server maintenance for our online platforms, such as OJS.
  • Crossref fees for generating Digital Object Identifiers (DOIs).
  • Paid plagiarism checks through Similarity Check/iThenticate.
  • Editorial office and staff.
Article categoryIndian and South Asian authorsForeign authors
Original research, systematic reviews, narrative reviews₹5,000USD 100
Case reports, short communications, letters to the editor, policy briefs₹3,000USD 50

There is no submission fee. Charges apply only if an article is accepted.

While we typically do not offer fee waivers or discounts, owing to these operational costs, we recognise that researchers, particularly in developing countries, may face financial constraints. In light of this, we are open to considering waivers and discounts on a case-by-case basis.

If financial considerations may pose challenges for you, we encourage you to reach out to us and explain your circumstances. We have previously granted fee waivers to researchers facing conditions such as:

  • Being based in countries experiencing war and/or economic crises.
  • Conducting exceptional research recognised with multiple awards.
  • Facing exceptional financial strain, particularly those from families classified under the Below Poverty Line (BPL) category.